News
Lineage Cell Therapeutics, Inc. Announces RG6501 (OpRegen) Phase 1/2a Clinical Study 24 Month Results To Be Featured At 2024 Retinal Cell & Gene Therapy Innovation Summit
13 Mar 24
Biotech, News, General
Lineage Cell Therapeutics Announces OpRegen Preclinical Engraftment Results To Be Presented At 2024 Association For Research In Vision And Ophthalmology Meeting
11 Mar 24
Biotech, News, Events, General
HC Wainwright & Co. Reiterates Buy on Lineage Cell Therapeutics, Maintains $7 Price Target
8 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Lineage Cell Therapeutics: Q4 Earnings Insights
7 Mar 24
Earnings
Lineage Cell Therapeutics Q4 2023 GAAP EPS $(0.030) Beats $(0.040) Estimate, Sales $2.100M Beat $1.310M Estimate
7 Mar 24
Earnings, Earnings Beats, News
Earnings Scheduled For March 7, 2024
7 Mar 24
Earnings
A Preview Of Lineage Cell Therapeutics's Earnings
6 Mar 24
Earnings
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
14 Feb 24
Movers
HC Wainwright & Co. Reiterates Buy on Lineage Cell Therapeutics, Maintains $7 Price Target
13 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Lineage Cell Therapeutics Announces $14M Million Registered Direct Offering
6 Feb 24
News, Offerings
Cantor Fitzgerald Reiterates Overweight on Lineage Cell Therapeutics, Maintains $6 Price Target
5 Feb 24
News, Price Target, Reiteration, Analyst Ratings
12 Health Care Stocks Moving In Thursday's After-Market Session
1 Feb 24
Movers
Press releases
RG6501 (OpRegen®) Phase 1/2a Clinical Study 24 Month Results to Be Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
13 Mar 24
Press Releases
RG6501 (OpRegen®) Preclinical Engraftment Results to Be Presented at 2024 Association for Research in Vision and Ophthalmology Meeting
11 Mar 24
Press Releases
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
7 Mar 24
Press Releases
Lineage Announces FDA Clearance of IND Amendment for OPC1 Cell Transplant for the Treatment of Spinal Cord Injury
13 Feb 24
Press Releases
Lineage Cell Therapeutics Announces Closing of $14.0 Million Registered Direct Offering
9 Feb 24
Press Releases
Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering
6 Feb 24
Press Releases